PNTG — Pennant Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedMid CapNeutral

Annual income statement for Pennant, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	391	440	473	545	695
Cost of Revenue
Gross Profit	94.1	86.6	103	110	142
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	372	435	461	520	657
Operating Profit	18.9	4.7	12.7	25.2	38.1
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	17.9	2.73	8.89	19.6	31.4
Provision for Income Taxes
Net Income After Taxes	15.6	2.15	7.24	13.9	24.3
Minority Interest
Net Income Before Extraordinary Items
Net Income	15.7	2.7	6.64	13.4	22.6
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	15.7	2.7	6.64	13.4	22.6
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.619	0.241	0.502	0.395	0.652